| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 墨旱莲皂苷II; Eclalbasaponin II | CFN70449 | 78285-90-3 | C36H58O9 = 634.9 | 5mg | QQ客服：1413575084 |
| 3-乙酰人参皂苷F1; 3-Acetyl-ginsenoside F1 | CFN95238 | 1881225-08-6 | C38H64O10 = 680.9 | 5mg | QQ客服：3257982914 |
| 七叶胆苷XIII; Gypenoside XIII | CFN95239 | 80325-22-0 | C41H70O12 = 755.0 | 10mg | QQ客服：215959384 |
| 桔梗酸A; Platycogenin A | CFN95240 | 1459719-53-9 | C42H68O16 = 829.0 | 5mg | QQ客服：215959384 |
| 远志皂苷D2; Polygalacin D2 | CFN95241 | 66663-92-1 | C63H102O32 = 1371.5 | 5mg | QQ客服：3257982914 |
| 绞股蓝皂苷L; Gypenoside L | CFN91854 | 94987-09-4 | C42H72O14 = 801.0 | 5mg | QQ客服：2056216494 |
| 绞股蓝皂苷LI; Gypenoside LI | CFN91853 | 94987-10-7 | C42H72O14 = 801.0 | 5mg | QQ客服：3257982914 |
| 泰国树脂酸-28-O-β-D-葡萄糖酯苷; Siaresinolic acid 28-O-beta-D-glucopyranosyl ester | CFN91847 | 155653-86-4 | C36H58O9 = 634.9 | 5mg | QQ客服：2056216494 |
| 达木林A; Damulin A | CFN91838 | 1202868-74-3 | C42H70O13 = 783.0 | 5mg | QQ客服：2159513211 |
| 达木林B; Damulin B | CFN91837 | 1202868-75-4 | C42H70O13 = 783.0 | 5mg | QQ客服：1457312923 |
| 牛膝皂苷C; Achyranthoside C | CFN91835 | 168009-90-3 | C47H72O20 = 957.1 | 5mg | QQ客服：2159513211 |
| 牛膝皂苷D; Achyranthoside D | CFN91834 | 168009-91-4 | C53H82O25 = 1119.2 | 5mg | QQ客服：215959384 |
| 达玛-20(22),24-二烯-3β,6α,12β-三醇; Quasipanaxatriol | CFN95248 | 171903-78-9 | C30H50O3 = 458.7 | 5mg | QQ客服：2159513211 |
| Arganine B; Arganine B | CFN95281 | 144425-21-8 | C63H102O33 = 1387.5 | 5mg | QQ客服：215959384 |
| 11-去氧异罗汉果苷V; 11-Deoxyisomogroside V | CFN95288 | 1628293-32-2 | C60H102O28 = 1271.5 | 10mg | QQ客服：2056216494 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)